CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83+0.05 (+6.00%)
Close on Nov 18, 2026Market cap $9.82MP/E –Yield –
CytoMed Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
CytoMed Therapeutics's price to book ratio was 1.9× on Nov 11, 2026, against 3.1× a year earlier. Over the last 4 years it ranged from 1.3× to 93.0×, with a median of 3.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.9× | −0.3 |
| 2025 | Dec 31, 2025 | 2.2× | −2.6 |
| 2024 | Dec 31, 2024 | 4.8× | −88.2 |
| 2023 | Dec 29, 2023 | 93.0× | – |
See a number that looks wrong?